Condition: Urothelial Cancer · Cancer · Bladder Neoplasms · Sponsor: Lahey Clinic
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
This description comes directly from the study's public registry record.
Kimberly Rieger-Christ, PhD · 781-744-2969 · Kimberly.R.Christ@lahey.org
Linda M. Topjian · 781-744-8711 · Linda.M.Topjian@Lahey.org
Always discuss trial participation with your own doctor first.
| Lahey Clinic, Inc. | Burlington, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00872495